Comparison of the protein profile of established and regressed hypertension-induced left ventricular hypertrophy

Julio Gallego-Delgado1, Alberto Lazaro, Julio I Osende

  • 1Renal and Vascular Pathology Laboratory, Fundación Jiménez Díaz-Universidad Autónoma, Madrid 28040, Spain.

Insights

Established left ventricular hypertrophy (LVH) alters cardiac proteins. Even after regression, some proteins characteristic of the hypertrophied heart persist, impacting energy, stress, and regulation.

Area of Science:

  • Cardiovascular Biology
  • Proteomics
  • Molecular Cardiology

Background:

  • Left ventricular hypertrophy (LVH) is a significant cardiac adaptation.
  • Hypertension is a common cause of pathological LVH.
  • Understanding the molecular changes in LVH is crucial for therapeutic development.

Purpose of the Study:

  • To identify specific protein expression changes in hypertension-induced LVH.
  • To investigate the cardiac proteome after LVH regression.
  • To determine the role of persistent proteins in cardiac function.

Main Methods:

  • Comparative proteomic analysis of cardiac tissue.
  • Histological determination of LVH regression.
  • Identification of differentially expressed proteins.

Main Results:

  • Established LVH exhibits a distinct cardiac protein profile compared to normal hearts.
  • Following LVH regression, a subset of proteins characteristic of the hypertrophied state remained altered.
  • These persistent proteins are involved in energy production, cellular stress response, and hypertrophy regulation.

Conclusions:

  • Cardiac protein alterations in LVH are not fully reversible even after histological regression.
  • Persistent proteins may contribute to long-term cardiac dysfunction or resilience.
  • Further research into these specific proteins could reveal novel therapeutic targets for managing cardiac remodeling.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...